Table 2 Clinical response to the DC vaccine
| Â | 3Â months | 6Â months | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical response | All patients | Alb ≥ 4.0 | Alb < 4.0 | All patients | Alb ≥ 4.0 | Alb < 4.0 | ||||||
| Â | N | % | N | % | N | % | N | % | N | % | N | % |
CR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PR | 2 | 3.6 | 2 | 5.5 | 0 | 0 | 1 | 1.8 | 1 | 2.8 | 0 | 0 |
SD | 14 | 25 | 11 | 30.6 | 3 | 15 | 7 | 12.5 | 5 | 13.9 | 2 | 10 |
PD | 32 | 57.1 | 19 | 52.8 | 13 | 65 | 42 | 75 | 27 | 75 | 15 | 75 |
NE | 8 | 14.3 | 4 | 11.1 | 4 | 20 | 6 | 10.7 | 3 | 8.3 | 3 | 15 |
Total | 56 | 100 | 36 | 100 | 20 | 100 | 56 | 100 | 36 | 100 | 20 | 100 |
ORR* | 2 | 3.6 | 2 | 5.5 | 0 | 0 | 1 | 1.8 | 1 | 2.8 | 0 | 0 |
DCR** | 16 | 28.6 | 13 | 36.1 | 3 | 15 | 8 | 14.3 | 6 | 16.7 | 2 | 10 |